Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 238, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2022.114435
Keywords
TRPM8 antagonists; Ca2+ -microfluorimetric assays; Electrophysiology; Anticancer activity; Castration-resistant prostate cancer cells spheroids
Categories
Funding
- Regione Campania-PON Campania FESR [B61G18000470007]
- Valere (Vanvitelli per la Ricerca)
- GoMAGIC/Universita degli Studi della Campania Luigi Vanvitelli
- Ministero dell'Istruzione, dell'Universita e della Ricerca [2017EKMFTN_002]
Ask authors/readers for more resources
This study describes the design and synthesis of a new series of TRPM8 antagonists, which were preliminarily characterized for potency and selectivity in vitro, showing remarkable efficacy in inhibiting the growth of prostate cancer cells.
TRPM8 has recently emerged as a druggable target in prostate cancer (PC) and TRPM8 modulators have been proposed as potential anticancer agents in this pathology. We have recently demonstrated their effectiveness in a castration-resistant prostate cancer (CRPC) model that is usually resistant to androgen deprivation therapy (ADT) and is considered the most aggressive form of PC. This is why the discovery of selective, effective, and potent TRPM8 modulators would improve the molecular arsenal in support of PC standard-of-care treatments. In the present paper we describe the design and the synthesis of a new series of TRPM8 antagonists, preliminarily characterized in vitro for their potency and selectivity by fluorimetric calcium assays. The preliminary screening allowed the identification of several potent (0.11 mu M < IC50 < 0.49 mu M) and selective compounds. The most potent derivatives were further characterized by patch-clamp electrophysiology assays, confirming their noteworthy activity. Moreover, the behavior of these compounds was investigated in 2D and 3D models of PC. These TRPM8 antagonists showed remarkable efficacy in inhibiting the growth induced by androgen in various PC cells as well as in CRPC models, confirming their potential as anticancer agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available